Pharmacokinetic and Pharmacodynamic Analyses To Determine the Optimal Fixed Dosing Regimen of Iclaprim for Treatment of Patients with Serious Infections Caused by Gram-Positive Pathogens [Experimental Therapeutics] - Lodise, T. P., Bosso, J., Kelly, C., Williams, P. J., Lane, J. R., Huang, D. B. (The American Society for Microbiology (ASM), 2018)
6146183